Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

St Louis, Missouri

Phase 1 colorectal cancer trials in St Louis, MO

30 Phase 1 colorectal cancer studies are recruiting participants at sites in St Louis as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

St Louis at a glance

  • 30 studies are recruiting at a site in St Louis.
  • By phase: Phase 1 (15), Phase 1/2 (15).
  • By sponsor: industry (26), university, hospital or other (3), government (1).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in St Louis

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    Washington University
    Registry record
    NCT05786924 · updated
  2. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    Washington University School of Medicine
    Registry record
    NCT06253871 · updated
  3. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    Washington University Medicine
    Registry record
    NCT06270706 · updated
  4. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT07020221 · updated
  5. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University
    Registry record
    NCT07114601 · updated
  6. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT07213791 · updated
  7. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Siteman Cancer Center
    Registry record
    NCT07397338 · updated
  8. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Washington University Medical Campus
    Registry record
    NCT05856981 · updated
  9. A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT07416552 · updated
  10. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Washington University School of Medicine at St Louis
    Registry record
    NCT03526835 · updated
  11. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    Washington University School of Medicine
    Registry record
    NCT07094204 · updated
  12. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Saint Louis University
    Registry record
    NCT06710756 · updated
  13. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Alterome Therapeutics, Inc.
    Registry record
    NCT06835569 · updated
  14. JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jacobio Pharmaceuticals Co., Ltd.
    Study site
    Washington University
    Registry record
    NCT06973564 · updated
  15. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Washington University
    Registry record
    NCT04657068 · updated
  16. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT06026410 · updated
  17. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT05919264 · updated
  18. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Washington University School of Medicine
    Registry record
    NCT06625775 · updated
  19. A Study of PHN-012 in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pheon Therapeutics
    Study site
    PHN-012-001 Site
    Registry record
    NCT07127874 · updated
  20. A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Angiex, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT06440005 · updated
  21. Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Siteman Cancer Center at Christian Hospital · Siteman Cancer Center-South County · Washington University School of Medicine
    Registry record
    NCT06696768 · updated
  22. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Washington University School of Medicine
    Registry record
    NCT04851119 · updated
  23. IDOV-Immune for Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ViroMissile, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT06910657 · updated
  24. AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Amgen
    Study site
    Siteman Cancer Center - Washington University
    Registry record
    NCT07094113 · updated
  25. Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MOMA Therapeutics
    Registry record
    NCT06974110 · updated
  26. Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Recursion Pharmaceuticals Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT05552755 · updated
  27. A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Turning Point Therapeutics, Inc.
    Study site
    Washington University Infusion Center Pharmacy
    Registry record
    NCT03093116 · updated
  28. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tasca Therapeutics
    Study site
    Washington University
    Registry record
    NCT07030257 · updated
  29. Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Washington University School of Medicine
    Registry record
    NCT03516708 · updated
  30. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Washington University
    Registry record
    NCT06682793 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Ask about studies near St Louis

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call